BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Faraldi M, Gomarasca M, Sansoni V, Perego S, Banfi G, Lombardi G. Normalization strategies differently affect circulating miRNA profile associated with the training status. Sci Rep. 2019;9:1584. [PMID: 30733582 DOI: 10.1038/s41598-019-38505-x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Lakkisto P, Dalgaard LT, Belmonte T, Pinto-Sietsma SJ, Devaux Y, de Gonzalo-Calvo D; EU-CardioRNA COST Action CA17129 (https://cardiorna.eu/). Development of circulating microRNA-based biomarkers for medical decision-making: a friendly reminder of what should NOT be done. Crit Rev Clin Lab Sci 2023;60:141-52. [PMID: 36325621 DOI: 10.1080/10408363.2022.2128030] [Reference Citation Analysis]
2 Aquino R, de Concini V, Dhenain M, Lam S, Gosset D, Baquedano L, Forero MG, Menuet A, Baril P, Pichon C. Intrahippocampal Inoculation of Aβ(1-42) Peptide in Rat as a Model of Alzheimer's Disease Identified MicroRNA-146a-5p as Blood Marker with Anti-Inflammatory Function in Astrocyte Cells. Cells 2023;12. [PMID: 36899831 DOI: 10.3390/cells12050694] [Reference Citation Analysis]
3 Guelfi G, Capaccia C, Santoro MM, Diverio S. Identification of Appropriate Endogenous Controls for Circulating miRNA Quantification in Working Dogs under Physiological Stress Conditions. Animals (Basel) 2023;13. [PMID: 36830363 DOI: 10.3390/ani13040576] [Reference Citation Analysis]
4 Lombardi G, Delvin E. Micro-RNA: A Future Approach to Personalized Diagnosis of Bone Diseases. Calcif Tissue Int 2023;112:271-87. [PMID: 35182198 DOI: 10.1007/s00223-022-00959-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Xhuti D, Nilsson MI, Manta K, Tarnopolsky MA, Nederveen JP. Circulating exosome-like vesicle and skeletal muscle microRNAs are altered with age and resistance training. J Physiol 2023. [PMID: 36722691 DOI: 10.1113/JP282663] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Rzepiel A, Horváth A, Kutszegi N, Gézsi A, Sági JC, Almási L, Egyed B, Lőrincz P, Visnovitz T, Kovács GT, Szalai C, Semsei ÁF, Erdélyi DJ. MiR-128-3p as blood based liquid biopsy biomarker in childhood acute lymphoblastic leukemia. Mol Cell Probes 2023;67:101893. [PMID: 36640912 DOI: 10.1016/j.mcp.2023.101893] [Reference Citation Analysis]
7 Baumann V, Athanasiou AT, Faridani OR, Schwerdtfeger AR, Wallner B, Steinborn R. Identification of extremely GC-rich micro RNAs for RT-qPCR data normalization in human plasma. Front Genet 2022;13:1058668. [PMID: 36685854 DOI: 10.3389/fgene.2022.1058668] [Reference Citation Analysis]
8 Kalli E. Omic-Based Biomarkers Discovery in Alzheimer’s Disease: High-Throughput Approaches. Handbook of Computational Neurodegeneration 2023. [DOI: 10.1007/978-3-319-75479-6_8-1] [Reference Citation Analysis]
9 El-Daly SM, Gouhar SA, Abd Elmageed ZY. Circulating microRNAs as Reliable Tumor Biomarkers: Opportunities and Challenges Facing Clinical Application. J Pharmacol Exp Ther 2023;384:35-51. [PMID: 35809898 DOI: 10.1124/jpet.121.000896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Aggio-Bruce R, Schumann U, Cioanca AV, Chen FK, McLenachan S, Heath Jeffery RC, Das S, Natoli R. Serum miRNA modulations indicate changes in retinal morphology. Front Mol Neurosci 2023;16:1130249. [PMID: 36937046 DOI: 10.3389/fnmol.2023.1130249] [Reference Citation Analysis]
11 Burlacu CC, Ciobanu D, Badulescu AV, Chelaru VF, Mitre AO, Capitanescu B, Hermann DM, Popa-Wagner A. Circulating MicroRNAs and Extracellular Vesicle-Derived MicroRNAs as Predictors of Functional Recovery in Ischemic Stroke Patients: A Systematic Review and Meta-Analysis. Int J Mol Sci 2022;24. [PMID: 36613694 DOI: 10.3390/ijms24010251] [Reference Citation Analysis]
12 Aggio-bruce R, Schumann U, Cioanca AV, Chen FK, Mclenachan S, Jeffery RCH, Das S, Natoli R. Serum miRNA modulations indicate changes in retinal morphology.. [DOI: 10.21203/rs.3.rs-2360031/v1] [Reference Citation Analysis]
13 Buchanan SR, Miller RM, Nguyen M, Black CD, Kellawan JM, Bemben MG, Bemben DA. Circulating microRNA responses to acute whole-body vibration and resistance exercise in postmenopausal women. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1038371] [Reference Citation Analysis]
14 Faulkner JL, Sullivan JC. Circulating cell-free micro-RNA as biomarkers: from myocardial infarction to hypertension. Clin Sci (Lond) 2022;136:1341-6. [PMID: 36129059 DOI: 10.1042/CS20220056] [Reference Citation Analysis]
15 Faraldi M, Sansoni V, Perego S, Gomarasca M, Gerosa L, Ponzetti M, Rucci N, Banfi G, Lombardi G. Acute changes in free and extracellular vesicle-associated circulating miRNAs and myokine profile in professional sky-runners during the Gran Sasso d’Italia vertical run. Front Mol Biosci 2022;9:915080. [DOI: 10.3389/fmolb.2022.915080] [Reference Citation Analysis]
16 Baldasici O, Pileczki V, Cruceriu D, Gavrilas LI, Tudoran O, Balacescu L, Vlase L, Balacescu O. Breast Cancer-Delivered Exosomal miRNA as Liquid Biopsy Biomarkers for Metastasis Prediction: A Focus on Translational Research with Clinical Applicability. Int J Mol Sci 2022;23:9371. [PMID: 36012638 DOI: 10.3390/ijms23169371] [Reference Citation Analysis]
17 Paterson E, Blenkiron C, Danielson K, Henry C. Recommendations for extracellular vesicle miRNA biomarker research in the endometrial cancer context. Transl Oncol 2022;23:101478. [PMID: 35820359 DOI: 10.1016/j.tranon.2022.101478] [Reference Citation Analysis]
18 Ruiz M, González S, Bonnet C, Deng SX. Extracellular miR-6723-5p could serve as a biomarker of limbal epithelial stem/progenitor cell population. Biomark Res 2022;10:36. [PMID: 35642012 DOI: 10.1186/s40364-022-00384-2] [Reference Citation Analysis]
19 Butz H. Circulating Noncoding RNAs in Pituitary Neuroendocrine Tumors-Two Sides of the Same Coin. Int J Mol Sci 2022;23. [PMID: 35563510 DOI: 10.3390/ijms23095122] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
20 Nail AN, Ferragut Cardoso AP, Banerjee M, States JC. Circulating miRNAs as Biomarkers of Toxic Heavy Metal Exposure. Genomic and Epigenomic Biomarkers of Toxicology and Disease 2022. [DOI: 10.1002/9781119807704.ch4] [Reference Citation Analysis]
21 Frydlova J, Zednikova I, Satrapova V, Pazourkova E, Santorova S, Hruskova Z, Tesar V, Vokurka M, Prikryl P, Korabecna M. Analysis of microRNAs in Small Urinary Extracellular Vesicles and Their Potential Roles in Pathogenesis of Renal ANCA-Associated Vasculitis. IJMS 2022;23:4344. [DOI: 10.3390/ijms23084344] [Reference Citation Analysis]
22 To NH, Nguyen HQ, Thiolat A, Liu B, Cohen J, Radosevic-Robin N, Belkacemi Y; TransAtlantic Radiation Oncology Network (TRONE) & Association of Radiotherapy, and Oncology of the Mediterranean Area (AROME). Radiation therapy for triple-negative breast cancer: emerging role of microRNAs as biomarkers and radiosensitivity modifiers. A systematic review. Breast Cancer Res Treat 2022. [PMID: 35397079 DOI: 10.1007/s10549-022-06533-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Chekka LMS, Langaee T, Johnson JA. Comparison of Data Normalization Strategies for Array-Based MicroRNA Profiling Experiments and Identification and Validation of Circulating MicroRNAs as Endogenous Controls in Hypertension. Front Genet 2022;13:836636. [DOI: 10.3389/fgene.2022.836636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Gomarasca M, Micielska K, Faraldi M, Flis M, Perego S, Banfi G, Ziemann E, Lombardi G. Impact of 12-Week Moderate-Intensity Aerobic Training on Inflammasome Complex Activation in Elderly Women. Front Physiol 2022;13:792859. [PMID: 35273516 DOI: 10.3389/fphys.2022.792859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Mancuso R, Agostini S, Hernis A, Caputo D, Galimberti D, Scarpini E, Clerici M. Alterations of the miR-126-3p/POU2AF1/Spi-B Axis and JCPyV Reactivation in Multiple Sclerosis Patients Receiving Natalizumab. Front Neurol 2022;13:819911. [DOI: 10.3389/fneur.2022.819911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 de Gonzalo-Calvo D, Marchese M, Hellemans J, Betsou F, Skov Frisk NL, Dalgaard LT, Lakkisto P, Foy C, Scherer A, Garcia Bermejo ML, Devaux Y; EU-CardioRNA COST Action CA17129 (https://cardiorna.eu/). Consensus guidelines for the validation of qRT-PCR assays in clinical research by the CardioRNA consortium. Mol Ther Methods Clin Dev 2022;24:171-80. [PMID: 35118162 DOI: 10.1016/j.omtm.2021.12.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Ban E, Song EJ. Considerations and Suggestions for the Reliable Analysis of miRNA in Plasma Using qRT-PCR. Genes 2022;13:328. [DOI: 10.3390/genes13020328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Ramirez-Garrastacho M, Berge V, Linē A, Llorente A. Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients. Br J Cancer 2022;126:492-501. [PMID: 34811506 DOI: 10.1038/s41416-021-01598-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
29 Guz M, Jeleniewicz W, Cybulski M. An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential. Int J Mol Sci 2022;23. [PMID: 35163157 DOI: 10.3390/ijms23031234] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
30 Trummer O, Foessl I, Schweighofer N, Arifi E, Haudum CW, Reintar S, Pilz S, Theiler-schwetz V, Trummer C, Zirlik A, Schmidt A, Colantonio C, Kolesnik E, Verheyen N, Pieber TR, Obermayer-pietsch B. Expression Profiles of miR-22-5p and miR-142-3p Indicate Hashimoto’s Disease and Are related to Thyroid Antibodies. Genes 2022;13:171. [DOI: 10.3390/genes13020171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 Podgórski R, Cieśla M, Podgórska D, Bajorek W, Płonka A, Czarny W, Trybulski R, Król P. Plasma microRNA-320a as a Potential Biomarker of Physiological Changes during Training in Professional Volleyball Players. J Clin Med 2022;11:263. [PMID: 35012004 DOI: 10.3390/jcm11010263] [Reference Citation Analysis]
32 Bardhi E, Mcdaniels J, Rousselle T, Maluf DG, Mas VR. Nucleic acid biomarkers to assess graft injury after liver transplantation. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100439] [Reference Citation Analysis]
33 Bošnjak M, Večerić-haler Ž, Boštjančič E, Kojc N. Renal Tissue miRNA Expression Profiles in ANCA-Associated Vasculitis—A Comparative Analysis. IJMS 2021;23:105. [DOI: 10.3390/ijms23010105] [Reference Citation Analysis]
34 Kaunein N, Ramani RS, Koo K, Moore C, Celentano A, McCullough M, Yap T. A Systematic Review of MicroRNA Signatures Associated with the Progression of Leukoplakia with and without Epithelial Dysplasia. Biomolecules 2021;11:1879. [PMID: 34944523 DOI: 10.3390/biom11121879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Cappelli K, Mecocci S, Capomaccio S, Beccati F, Palumbo AR, Tognoloni A, Pepe M, Chiaradia E. Circulating Transcriptional Profile Modulation in Response to Metabolic Unbalance Due to Long-Term Exercise in Equine Athletes: A Pilot Study. Genes (Basel) 2021;12:1965. [PMID: 34946914 DOI: 10.3390/genes12121965] [Reference Citation Analysis]
36 Schofield AL, Brown JP, Brown J, Wilczynska A, Bell C, Glaab WE, Hackl M, Howell L, Lee S, Dear JW, Remes M, Reeves P, Zhang E, Allmer J, Norris A, Falciani F, Takeshita LY, Seyed Forootan S, Sutton R, Park BK, Goldring C. Systems analysis of miRNA biomarkers to inform drug safety. Arch Toxicol 2021;95:3475-95. [PMID: 34510227 DOI: 10.1007/s00204-021-03150-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
37 Dakterzada F, David Benítez I, Targa A, Lladó A, Torres G, Romero L, de Gonzalo-Calvo D, Moncusí-Moix A, Tort-Merino A, Huerto R, Sánchez-de-la-Torre M, Barbé F, Piñol-Ripoll G. Reduced Levels of miR-342-5p in Plasma Are Associated With Worse Cognitive Evolution in Patients With Mild Alzheimer's Disease. Front Aging Neurosci 2021;13:705989. [PMID: 34497505 DOI: 10.3389/fnagi.2021.705989] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
38 Cirillo PDR, Margiotti K, Fabiani M, Barros-Filho MC, Sparacino D, Cima A, Longo SA, Cupellaro M, Mesoraca A, Giorlandino C. Multi-analytical test based on serum miRNAs and proteins quantification for ovarian cancer early detection. PLoS One 2021;16:e0255804. [PMID: 34352040 DOI: 10.1371/journal.pone.0255804] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
39 Jones TL, Esa MS, Li KHC, Krishnan SRG, Elgallab GM, Pearce MS, Young DA, Birrell FN. Osteoporosis, fracture, osteoarthritis & sarcopenia: A systematic review of circulating microRNA association. Bone 2021;152:116068. [PMID: 34166859 DOI: 10.1016/j.bone.2021.116068] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
40 Pedersen OB, Grove EL, Kristensen SD, Nissen PH, Hvas AM. MicroRNA as Biomarkers for Platelet Function and Maturity in Patients with Cardiovascular Disease. Thromb Haemost 2021. [PMID: 34091883 DOI: 10.1055/s-0041-1730375] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
41 O'Farrell HE, Bowman RV, Fong KM, Yang IA. Plasma Extracellular Vesicle miRNAs Can Identify Lung Cancer, Current Smoking Status, and Stable COPD. Int J Mol Sci 2021;22:5803. [PMID: 34071592 DOI: 10.3390/ijms22115803] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
42 Faraldi M, Gerosa L, Gomarasca M, Sansoni V, Perego S, Ziemann E, Banfi G, Lombardi G. A Physically Active Status Affects the Circulating Profile of Cancer-Associated miRNAs. Diagnostics (Basel) 2021;11:820. [PMID: 33946605 DOI: 10.3390/diagnostics11050820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Ravanidis S, Grundler F, de Toledo FW, Dimitriou E, Tekos F, Skaperda Z, Kouretas D, Doxakis E. Fasting-mediated metabolic and toxicity reprogramming impacts circulating microRNA levels in humans. Food Chem Toxicol 2021;152:112187. [PMID: 33839215 DOI: 10.1016/j.fct.2021.112187] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
44 Lee S, Baker ME, Clinton M, Taylor SE. Use of Omics Data in Fracture Prediction; a Scoping and Systematic Review in Horses and Humans. Animals (Basel) 2021;11:959. [PMID: 33808497 DOI: 10.3390/ani11040959] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Knyazeva MS, Prisyazhnaya ТS, Zabegina LM, Smirnova ОA, Mikhetko AA, Berlev IV, Malek AV. Prognostic value of microRNA assessment in cervical epithelial cells of patients with mild dysplasia. Opuholi ženskoj reproduktivnoj sistemy 2021;16:66-75. [DOI: 10.17650/1994-4098-2020-16-4-66-75] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Ntelios D, Georgiou E, Alexouda S, Malousi A, Efthimiadis G, Tzimagiorgis G. A critical approach for successful use of circulating microRNAs as biomarkers in cardiovascular diseases: the case of hypertrophic cardiomyopathy. Heart Fail Rev 2021. [PMID: 33656618 DOI: 10.1007/s10741-021-10084-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
47 Flowers E, Ramírez-mares J, Velazquez-villafaña M, Rangel-salazar R, Sucher A, Kanaya AM, Aouizerat BE, de la Vega Monroy MLL. Circulating microRNAs associated with prediabetes and geographic location in Latinos. Int J Diabetes Dev Ctries 2021;41:570-8. [DOI: 10.1007/s13410-020-00917-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Damanti CC, Gaffo E, Lovisa F, Garbin A, Di Battista P, Gallingani I, Tosato A, Pillon M, Carraro E, Mascarin M, Elia C, Biffi A, Bortoluzzi S, Mussolin L. MiR-26a-5p as a Reference to Normalize MicroRNA qRT-PCR Levels in Plasma Exosomes of Pediatric Hematological Malignancies. Cells 2021;10:E101. [PMID: 33429910 DOI: 10.3390/cells10010101] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
49 Abdelaal NE, Abdelhai MF. Differential Expression of Exosomal MicroRNAs in Neurodegenerative Diseases. Role of Exosomes in Biological Communication Systems 2021. [DOI: 10.1007/978-981-15-6599-1_9] [Reference Citation Analysis]
50 Papaneophytou C, Galatou E, Felekkis K. Good laboratory and experimental practices for microRNA analysis in cardiovascular research. Epigenetics in Cardiovascular Disease 2021. [DOI: 10.1016/b978-0-12-822258-4.00002-x] [Reference Citation Analysis]
51 Huai Y, Li H, Tian Y, Qian A, Chen Z. MicroRNAs and the Diagnosis of Osteoporosis. Noncoding RNAs and Bone 2021. [DOI: 10.1007/978-981-16-2402-5_2] [Reference Citation Analysis]
52 Dakterzada F, Targa A, Benítez ID, Romero-ElKhayat L, de Gonzalo-Calvo D, Torres G, Moncusí-Moix A, Huerto R, Sánchez-de-la-Torre M, Barbé F, Piñol-Ripoll G. Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease. Alzheimers Res Ther 2020;12:163. [PMID: 33278902 DOI: 10.1186/s13195-020-00735-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
53 Viscardi G, Di Natale D, Fasano M, Brambilla M, Lobefaro R, De Toma A, Galli G. Circulating biomarkers in malignant pleural mesothelioma. Exploration of Targeted Anti-tumor Therapy 2020;1. [DOI: 10.37349/etat.2020.00028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Mehta P. MicroRNA research: The new dawn of Tuberculosis. Indian J Tuberc 2021;68:321-9. [PMID: 34099196 DOI: 10.1016/j.ijtb.2020.11.011] [Reference Citation Analysis]
55 Chong ZX, Yeap SK, Ho WY. Roles of circulating microRNA(s) in human breast cancer. Archives of Biochemistry and Biophysics 2020;695:108583. [DOI: 10.1016/j.abb.2020.108583] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
56 Howell SJ, Brown OI, Beattie WS. Aetiology of perioperative myocardial injury: a scientific conundrum with profound clinical implications. British Journal of Anaesthesia 2020;125:642-6. [DOI: 10.1016/j.bja.2020.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
57 Tolnai E, Fidler G, Szász R, Rejtő L, Nwozor KO, Biró S, Paholcsek M. Free circulating mircoRNAs support the diagnosis of invasive aspergillosis in patients with hematologic malignancies and neutropenia. Sci Rep 2020;10:16532. [PMID: 33020578 DOI: 10.1038/s41598-020-73556-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
58 Grabia S, Smyczynska U, Pagacz K, Fendler W. NormiRazor: tool applying GPU-accelerated computing for determination of internal references in microRNA transcription studies. BMC Bioinformatics 2020;21:425. [PMID: 32993488 DOI: 10.1186/s12859-020-03743-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
59 Mussbacher M, Krammer TL, Heber S, Schrottmaier WC, Zeibig S, Holthoff HP, Pereyra D, Starlinger P, Hackl M, Assinger A. Impact of Anticoagulation and Sample Processing on the Quantification of Human Blood-Derived microRNA Signatures. Cells 2020;9:E1915. [PMID: 32824700 DOI: 10.3390/cells9081915] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
60 Cirillo PDR, Margiotti K, Mesoraca A, Giorlandino C. Quantification of circulating microRNAs by droplet digital PCR for cancer detection. BMC Res Notes 2020;13:351. [PMID: 32703272 DOI: 10.1186/s13104-020-05190-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
61 Nair VD, Ge Y, Li S, Pincas H, Jain N, Seenarine N, Amper MAS, Goodpaster BH, Walsh MJ, Coen PM, Sealfon SC. Sedentary and Trained Older Men Have Distinct Circulating Exosomal microRNA Profiles at Baseline and in Response to Acute Exercise. Front Physiol 2020;11:605. [PMID: 32587527 DOI: 10.3389/fphys.2020.00605] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
62 Verdelli C, Sansoni V, Perego S, Favero V, Vitale J, Terrasi A, Morotti A, Passeri E, Lombardi G, Corbetta S. Circulating fractures-related microRNAs distinguish primary hyperparathyroidism-related from estrogen withdrawal-related osteoporosis in postmenopausal osteoporotic women: A pilot study. Bone 2020;137:115350. [PMID: 32380256 DOI: 10.1016/j.bone.2020.115350] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
63 Pastor-Navarro B, García-Flores M, Fernández-Serra A, Blanch-Tormo S, Martínez de Juan F, Martínez-Lapiedra C, Maia de Alcantara F, Peñalver JC, Cervera-Deval J, Rubio-Briones J, García-Rupérez J, López-Guerrero JA. A Tetra-Panel of Serum Circulating miRNAs for the Diagnosis of the Four Most Prevalent Tumor Types. Int J Mol Sci 2020;21:E2783. [PMID: 32316350 DOI: 10.3390/ijms21082783] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
64 Bottani M, Banfi G, Lombardi G. The Clinical Potential of Circulating miRNAs as Biomarkers: Present and Future Applications for Diagnosis and Prognosis of Age-Associated Bone Diseases. Biomolecules 2020;10:E589. [PMID: 32290369 DOI: 10.3390/biom10040589] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
65 Valihrach L, Androvic P, Kubista M. Circulating miRNA analysis for cancer diagnostics and therapy. Molecular Aspects of Medicine 2020;72:100825. [DOI: 10.1016/j.mam.2019.10.002] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 18.3] [Reference Citation Analysis]
66 Xu P, Wu Q, Yu J, Rao Y, Kou Z, Fang G, Shi X, Liu W, Han H. A Systematic Way to Infer the Regulation Relations of miRNAs on Target Genes and Critical miRNAs in Cancers. Front Genet 2020;11:278. [PMID: 32296462 DOI: 10.3389/fgene.2020.00278] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
67 Iacob DG, Rosca A, Ruta SM. Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis. World J Gastroenterol 2020; 26(11): 1113-1127 [PMID: 32231417 DOI: 10.3748/wjg.v26.i11.1113] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
68 Ruiz-Tagle C, Naves R, Balcells ME. Unraveling the Role of MicroRNAs in Mycobacterium tuberculosis Infection and Disease: Advances and Pitfalls. Infect Immun 2020;88:e00649-19. [PMID: 31871103 DOI: 10.1128/IAI.00649-19] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
69 Felekkis K, Papaneophytou C. Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases. Int J Mol Sci 2020;21:E561. [PMID: 31952319 DOI: 10.3390/ijms21020561] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
70 Lembeck AL, Puchas P, Hutterer G, Barth DA, Terbuch A, Bauernhofer T, Pichler M. MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients. Noncoding RNA 2020;6:E2. [PMID: 31906360 DOI: 10.3390/ncrna6010002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
71 Faraldi M, Sansoni V, Perego S, Gomarasca M, Kortas J, Ziemann E, Banfi G, Lombardi G. Study of the preanalytical variables affecting the measurement of clinically relevant free-circulating microRNAs: focus on sample matrix, platelet depletion, and storage conditions. Biochem Med (Zagreb) 2020;30:010703. [PMID: 31839723 DOI: 10.11613/BM.2020.010703] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
72 Velasco-Torres Y, Ruiz V, Montaño M, Pérez-Padilla R, Falfán-Valencia R, Pérez-Ramos J, Pérez-Bautista O, Ramos C. Participation of the miR-22-HDAC4-DLCO Axis in Patients with COPD by Tobacco and Biomass. Biomolecules 2019;9:E837. [PMID: 31817742 DOI: 10.3390/biom9120837] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
73 Ravanidis S, Bougea A, Papagiannakis N, Maniati M, Koros C, Simitsi AM, Bozi M, Pachi I, Stamelou M, Paraskevas GP, Kapaki E, Moraitou M, Michelakakis H, Stefanis L, Doxakis E. Circulating Brain-enriched MicroRNAs for detection and discrimination of idiopathic and genetic Parkinson's disease. Mov Disord 2020;35:457-67. [PMID: 31799764 DOI: 10.1002/mds.27928] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
74 Cacheux J, Bancaud A, Leichlé T, Cordelier P. Technological Challenges and Future Issues for the Detection of Circulating MicroRNAs in Patients With Cancer. Front Chem 2019;7:815. [PMID: 31850308 DOI: 10.3389/fchem.2019.00815] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
75 Velasco-Torres Y, Ruiz-López V, Pérez-Bautista O, Buendía-Roldan I, Ramírez-Venegas A, Pérez-Ramos J, Falfán-Valencia R, Ramos C, Montaño M. miR-34a in serum is involved in mild-to-moderate COPD in women exposed to biomass smoke. BMC Pulm Med 2019;19:227. [PMID: 31775690 DOI: 10.1186/s12890-019-0977-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
76 Bottani M, Banfi G, Lombardi G. Perspectives on miRNAs as Epigenetic Markers in Osteoporosis and Bone Fracture Risk: A Step Forward in Personalized Diagnosis. Front Genet 2019;10:1044. [PMID: 31737038 DOI: 10.3389/fgene.2019.01044] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
77 Connor KL, Denby L. MicroRNAs as non-invasive biomarkers of renal disease. Nephrol Dial Transplant 2021;36:428-9. [PMID: 31539062 DOI: 10.1093/ndt/gfz183] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
78 Szelenberger R, Kacprzak M, Saluk-Bijak J, Zielinska M, Bijak M. Plasma MicroRNA as a novel diagnostic. Clin Chim Acta 2019;499:98-107. [PMID: 31499022 DOI: 10.1016/j.cca.2019.09.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]